India
· Delayed Price · Currency is INR JBCHEPHARM Statistics
Total Valuation
J. B. Chemicals & Pharmaceuticals has a market cap or net worth of INR 291.80 billion. The enterprise value is 290.98 billion.
| Market Cap | 291.80B |
| Enterprise Value | 290.98B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | Aug 14, 2024 |
Share Statistics
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.18% |
| Shares Change (QoQ) | +1.23% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 71.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 49.56 |
| EV / Sales | 8.10 |
| EV / EBITDA | 31.14 |
| EV / EBIT | 36.68 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.40 |
| Debt / FCF | n/a |
| Interest Coverage | 21.31 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 15.61% |
| Revenue Per Employee | 6.76M |
| Profits Per Employee | 1.11M |
| Employee Count | 5,311 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.25% in the last 52 weeks. The beta is -0.04, so J. B. Chemicals & Pharmaceuticals's price volatility has been lower than the market average.
| Beta (5Y) | -0.04 |
| 52-Week Price Change | +35.25% |
| 50-Day Moving Average | 1,884.72 |
| 200-Day Moving Average | 1,791.20 |
| Relative Strength Index (RSI) | 62.06 |
| Average Volume (20 Days) | 238,648 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, J. B. Chemicals & Pharmaceuticals had revenue of INR 35.92 billion and earned 5.87 billion in profits. Earnings per share was 36.94.
| Revenue | 35.92B |
| Gross Profit | 23.48B |
| Operating Income | 7.93B |
| Pretax Income | 7.97B |
| Net Income | 5.87B |
| EBITDA | 9.34B |
| EBIT | 7.93B |
| Earnings Per Share (EPS) | 36.94 |
Balance Sheet
The company has 4.60 billion in cash and 3.78 billion in debt, giving a net cash position of 819.79 million.
| Cash & Cash Equivalents | 4.60B |
| Total Debt | 3.78B |
| Net Cash | 819.79M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 29.23B |
| Book Value Per Share | 188.37 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 65.37%, with operating and profit margins of 22.08% and 16.34%.
| Gross Margin | 65.37% |
| Operating Margin | 22.08% |
| Pretax Margin | 22.19% |
| Profit Margin | 16.34% |
| EBITDA Margin | 26.01% |
| EBIT Margin | 22.08% |
| FCF Margin | n/a |
Dividends & Yields
J. B. Chemicals & Pharmaceuticals does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | 38.03% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -1.18% |
| Shareholder Yield | -1.18% |
| Earnings Yield | 1.96% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on September 18, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Sep 18, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |